2025

• Kubo A, Sanaka S, Shinoda N, Sasaki T. Development of a treatment for autism spectrum disorder that targets the brain’s immune system – A treatment strategy that controls synaptic pruning via microglia and the complement system -. Bio Clinica. 2025-02. Vol. 40 No.3. 41-42. 
• Sanaka S, Sasaki T. Pharmacological Treatment of Autism Spectrum Disorder: Evidence and Clinical Decision-Making in Practice. Clinical Psychopharmacology. 2025-02. 28 (04). 101-108. in press.
• Sanaka S, Sasaki T, Takei Y. Neuroimmune Interactions in Autism Spectrum Disorder: IL-17A-dependent Microglial Modulation and Pathophysiology. 2025-03. Clinical Psychiatry. 67(3): in press.
• Kamiya S, Sanaka S, Kubo A, Higuchi K, Nakamura K, Sasaki T. Multifaceted Potential of IL-17 Inhibitors: From Skin to Brain. 2025-03. Allergy and rheumatic diseases. Vol. 45. No.2. 72-73.
• Iwata S, Hyugaji M, Soga Y, Morikawa M, Sasaki T, Takei Y. Gene expression of psychiatric disorder-related kinesin superfamily proteins (Kifs) is potentiated in alternatively activated primary cultured microglia. BMC research notes. 18(44) 1-8. 
• Iwata S, Hoshino T, Aoki S, Takei Y, and Itoh M. High-speed three-dimensional cross-sectional measurement of cultured neurons by scatterometry that improves resolution by an order of magnitude. Optics Express Vol. 33, Issue 5, pp. 11398-11408 (2025)
• Kubo A, Morikawa M, Iwata S, Sasaki T, Takei Y. Spatiotemporal analysis of IL-17RA/RC expression in the cerebral cortex: examination of neuroimmunological links using a model of psychiatric disorders. Tsukuba Journal of Biology. 2025-02. 24 (1). in press.
• Hyugaji, Morikawa M,  Sasaki T, Iwata S, Takei Y. Elucidation of the role of the schizophrenia-related kinesin KIF17 in microglial morphological changes. Tsukuba Journal of Biology. 2025-09. 24 (1). in press.
• Kubo A, Kamiya S, Nakamura K, Higuchi K, Sanaka S, Kishi K, Takei Y. Sasaki T. Expression Dynamics of IL-17RA mRNA in the Cerebral Cortex and Its Changes in Animal Models of ASD. DoHAD Research. 2025-01. 12(3): 186-186.
• Kamiya S, Kubo A, Higuchi K, Nakamura K, Sanaka S, Kishi K, Takei Y. Sasaki T. The Role of Immune Molecules in Central Nervous System Development and Their Dysregulation in ASD. DoHAD Research. 2025-01. 12(3): 203-203.
• Sakamoto C, Sanaka S, Sasaki T. Interleukin-17A (IL-17A): Molecular Characteristics and Its Physiological and Pathological Significance – From Molecular Structure to Clinical Applications. Clinical Psychopharmacology. 2025-05.
• Sasaki T, Kamiya S, Kishi K, Iwata S, Takei. Y. Expression patterns of IL-17 receptors in the cerebral cortex during postnatal development and its alteration by maternal immune activation. The international journal of neuropsychopharmacology. 28(1). i259-259. 2025-02.
• Kamiyama Y, Morikawa M, Sasaki, Iwata S, Takei Y. Molecular Mechanism regulating the activity-dependent KIF17 degradation underlying memory retrieval. Graduation Thesis Collection of College of Medical Sciences, School of Medicine and Health Sciences, University of Tsukuba. 22(1): 25-26. 2025.03.
• Nakamura K, Kamiya S, Sasaki T. Molecular Basis for the Structural Organization and Functional Specificity of the Primate Prefrontal Cortex. Medical Science Digest. 51(5): 40-41.
• 久保明澄, 左中彩恵, 篠田希乃佳, 佐々木哲也. 脳内免疫系を標的とした自閉スペクトラム症治療薬の開発. Bio Clinica. 2025-02. Vol. 40 No.3. 15-16. 
• 左中彩恵, 佐々木哲也. 自閉スペクトラム症の薬物療法: エビデンスと臨床判断の実際. 臨床精神薬理. 2025-02. 28 (04). 101-108.  
• 久保明澄, 佐々木哲也. 第12回日本DOHaD学会学術集会参加レポート. DOHaD研究. 2025-03. Vol.13 No.1 21-30. 
• 左中彩恵, 佐々木哲也, 武井陽介. 免疫-脳連関から見た自閉スペクトラム症の病態理解-IL-17Aによるミクログリア機能修飾の観点から-. 精神医学. 67(3): in press.
• 篠田希乃佳, 佐々木哲也, 武井陽介. Effects of visual memory on aggression in mice by glutamate receptors in the brain. 2024年度ARE報告書. 2025-02.
• 坂本智佳子, 佐々木哲也, 武井陽介. Mechanisms of psychiatric disease onset by activation of maternal immune response. 2024年度ARE報告書. 2025-02.
• 中村賢佑, 佐々木哲也. 第 112 回日本解剖学会関東支部学術集会に参加して. 桐医会会報. 2025-09. No.98. in press.
• 左中彩恵. 一歩踏み出した先にある世界-研究室演習で得た学びと気づき-.  桐医会会報. 2025-09. No.98. in press.
• 坂本智佳子. 研究を発信するということ. 桐医会会報. 2025-09. No.98. in press.

2024

• Yoshihara M, Watabe Y, Morikawa M, Iwata S, Hamada M, Sasaki T, Homma N, Takei Y. A case report of an Adachi-Williams type CG plus H aortic arch anomaly and implications for the development of the cervicothoracic circulation. Folia Morphologica. 2024. in press. 
• Kamiya S, Kubo A, Higuchi K, Nakamura K, Kishi K, Sasaki T. Maternal immune activation and abortion: The Role of IL-17A. Reproductive Immunology and Biology. 2024-12. 39(1): 41-50.
• Kamiya S, Sasaki T. Fetal Environment and Neurodevelopment: The Role of Maternal Immune System and Microbiota in Autism Spectrum Disorder. Reproductive Immunology and Biology. 2024-12. 39(1): 51-59.
• Kubo A, Kamiya S, Sasaki T. Effects of Maternal Immune Activation and IL-17A on Abortion. BIO Clinica. 2024-09. 39(10): 38-40.
• Kamiya S, Sanaka S, Kubo A, Higuchi K, Kishi K, Sasaki T. IL-17: A Bridge from Psoriasis to Autism. Precision Medicine. 2024-09. Vol.7 No.11. 35-36. 
• Nakamura K, Kamiya S, Sasaki T. Molecular Basis of Neural Circuits Specific to the Prefrontal Cortex in Primates. THE CELL. 2024-08. 56(10): 65-66. 
• Sanaka S, Higuchi K, Nakamura K. Morikawa M, Iwata S, Sasaki T, Takei Y. Microstructural abnormalities of the cerebral cortex and autism spectrum disorders: from human pathology to animal models. Medical Science Digest. 2024-09. Vol. 50 No.11. 488-489. 
• Kamiya S, Sanaka S, Kubo A, Higuchi K, Kishi K, Sasaki T. Psoriasis and ASD: Revolutionary Insights into Disease Mechanisms through IL-17. The Allergy in Practice. 2024-10. Vol. 44 No.12. 70-71. 
• Kubo A, Sanaka S, Shinoda N, Sasaki T. Development of a treatment for autism spectrum disorder that targets the brain’s immune system – A treatment strategy that controls synaptic pruning via microglia and the complement system -. Bio Clinica. 2025-02. Vol. 40 No.3. 15-16. 
• Kamiya S, Takei Y, Iwata S, Sasaki T. IL-17A mRNA expression in the cerebral cortex during postnatal development and its alternations in an animal model of ASD. Tsukuba Journal of Biology. 2024. 23(1): 42-42.
• Kubo A, Kamiya S, Higuchi K, Nakamura K, Sanaka S, Sasaki T. Prenatal Valproic Acid Exposure and Autism Spectrum Disorder: An Integrative Review of Developmental Neurotoxicity Mechanisms and Animal Models. 2024-12. DOHaD Research 12 (3). 15-24. in press.
• Kubo A, Kamiya S, Higuchi K, Nakamura K, Sanaka K, Sasaki T. How Does Maternal Immune Activity Affect Fetal Survival and Brain Development?: The critical roles of IL-17A and microglia. Jxiv. 2024.
• Kubo A, Sasaki T. Neuroimmune IL-17 Axis: Psoriasis and ASD. Jxiv. 2024.
• Higuchi K , Nakamura K, Kubo A , Sanaka S , Kamiya S , Sasaki T. Cytoskeletal and Motor Abnormalities in Schizophrenia and ASD. Jxiv. 2024.
• Kamiya S, Sasaki T. Fetal Environment and Neurodevelopment: The Role of Maternal Immune System and Microbiota in Autism Spectrum Disorder. Jxiv. 2024.
• Nakamura K, Sanaka S, Higuchi K, Kubo A, Kamiya S, Sasaki T. Elucidating the Pathogenic Mechanisms of Autism Spectrum Disorder Using Brain Organoids: Assessment of Environmental Factors and Challenges. 2024-09. Jxiv.
• Kubo A, Kamiya S, Higuchi K, Nakamura K, Sanaka S, Sasaki T. Prenatal Valproic Acid Exposure and Autism Spectrum Disorder: An Integrative Review of Developmental Neurotoxicity Mechanisms and Animal Models. 2024-09. Jxiv.
• Sasaki T, Nakamura K, Sanaka S, Higuchi K, Kamiya S, Kubo A. Anatomia Nova: The Evolution and Prospects of Anatomy in the Era of Human Augmentation Technology – An Integrative Review of Structure, Function, and Ethics. 2024-10. Jxiv.
• Nakamura K, Sanaka S, Higuchi K, Kubo A, Kamiya S, Sasaki T. From Sensory Quirks to Superhuman Tech: Pioneering Support Strategies for Autism Spectrum Disorder. 2024-10. Jxiv.
• Sakamoto C, Sanaka S, Kamiya S, Kubo A, Nakamura K, Higuchi K, Sasaki T. Interleukin-17A (IL-17A): Molecular Characteristics and Its Physiological and Pathological Significance – From Molecular Structure to Clinical Applications. 2024-11. Jxiv.
• Sasaki T, Sanaka S, Kamiya S. Pharmacological Treatment of Autism Spectrum Disorder: Evidence and Clinical Decision Making in Practice. 2024-12. Jxiv.
• Kubo A, Sanaka S, Shinoda N, Sasaki T. Development of a treatment for autism spectrum disorder that targets the brain’s immune system – A treatment strategy that controls synaptic pruning via microglia and the complement system -. 2025-01. Jxiv.
• Nakamura K, Sanaka S, Higuchi K, Kubo A, Kamiya S, Sasaki T. Autism Research Using Brain Organoids: Environmental Factors and Genetic Background. 2024-12. Struc Func. in press.
• Nakamura K, Kamiya S, Sasaki T. Laboratory Exercises in Laboratory of Anatomy&Neuroscience. Bulletin in Touikai. 2024-09. 65: 65-66.
• Sasaki T, Kamiya S, Nakamura K. Introduction of Laboratory: Laboratory of Anatomy and Neuroscience, Faculty of Medicine, University of Tsukuba. Bulletin in Touikai. 2024-09. 65: 61-64.
• Sasaki T, Kubo A, Kamiya S, Higuchi K, Nakamura K. Enhanced maternal ROR γt enhances the effect of poly (I:C) in inducing fetal loss. Reproductive Immunology and Biology. 2024. 39(1): in press.
• Higuchi K, Kubo A, Kamiya S, Nakamura K, Sanaka S, Sasaki T. The Interplay of Psoriasis, Autism Spectrum Disorder, and Allergic Diseases: An Integrative Review of Pathogenic Mechanisms. Clinical Immunology/ Allergy. 82(6) in press.
• Kamiya S, Kubo A, Higuchi K, Kishi K, Sasaki T. Maternal Immune Activation as an Environmental Factor in Autism: Perspectives from the DoHAD Theory. 2024.  in press.
• Kubo A, Kamiya S, Nakamura K, Higuchi K, Sanaka S, Kishi K, Takei Y. Sasaki T. Expression Dynamics of IL-17RA mRNA in the Cerebral Cortex and Its Changes in Animal Models of ASD. DoHAD Research. 2024. 12(3): 186-186.
• Kamiya S, Kubo A, Higuchi K, Nakamura K, Sanaka S, Kishi K, Takei Y. Sasaki T. The Role of Immune Molecules in Central Nervous System Development and Their Dysregulation in ASD. DoHAD Research. 2024. 12(3): 203-203.
• 中村賢佑, 神谷沙羅, 佐々木哲也. 解剖学・神経科学研究室における研究室演習-精神疾患の生物学的基盤の解明を目指す-. 2024-09. 65(1): 61-64. 桐医会会報. 
• 佐々木哲也, 神谷沙羅, 中村賢佑. 解剖学・神経科学研究室のこれまでとこれから-新しい解剖学を追い求めて-. 2024-09. 65(1): 65-66. 桐医会会報. 
• 久保明澄, 神谷沙羅, 佐々木哲也. 母体免疫活性化による流産: IL-17Aに着目して. Bio Clinica. 39(10): 38-40. 2024-09. 
• 中村賢佑, 神谷沙羅, 佐々木哲也. 霊長類の前頭前皮質の神経回路を特徴づける分子基盤. 細胞.  56(10): 65-66. 2024-08
• 神谷沙羅, 左中彩恵, 久保明澄, 樋口浩輝, 中村賢佑, 佐々木哲也. IL-17：乾癬から自閉症への架け橋. Precision Medicine. 2024. Vol.7 No.11. 35-36. 2024-09.
• 左中彩恵, 樋口浩輝, 中村賢佑, 森川桃, 岩田卓, 佐々木哲也, 武井陽介. 大脳皮質の微細構造異常と自閉スペクトラム症：ヒトの病理から動物モデルまで. Medical Science Digest. Vol. 50 No.11. 488-489. 2024-09. 
• 神谷沙羅; 左中彩恵; 久保明澄; 樋口浩輝; 中村賢祐; 佐々木哲也. 乾癬と自閉スペクトラム症：IL-17を介した疾患理解の革新. アレルギーの臨床. Vol44 No.12. 70-71. 2024-10.
• 樋口浩輝, 神谷沙羅, 久保明澄, 中村 賢佑, 左中 彩恵, 佐々木哲也. 免疫-神経-環境軸から見る自閉スペクトラム症・アレルギー・乾癬： 異なる疾患群に潜む共通病態メカニズムの探求. 臨床免疫・アレルギー科. Vol. 82 No. 4. 2024-12. in press.
• 久保明澄, 神谷沙羅, 樋口浩輝, 中村 賢佑, 左中 彩恵, 佐々木哲也. バルプロ酸胎生期曝露と自閉スペクトラム症 -発達神経毒性メカニズムと動物モデルの統合的考察-. DOHaD Research. 12(3): 15-24. 2024-12. in press.
• 森川桃. 筑波大学着任の挨拶. 2024-03.
• 宇田川淳, 岡村結, 樋口浩輝, 吉原雅大, 渡部嘉徳. 筑波大学 剖出の手引き: 第一版. 2024.05.01. 株式会社イセブ.
• 宇田川淳, 岡村結, 樋口浩輝, 吉原雅大, 渡部嘉徳 (改訂: 吉原雅大, 渡部嘉徳). 筑波大学 剖出の手引き: 第二版. 2024.10.25. 株式会社イセブ.
• 篠田希乃佳. ARE第3回中間報告会に参加して. 2024-10.
• 坂本智佳子. ARE第2回中間報告会に参加して. 2024-10.
• 中村賢佑. 第 112 回日本解剖学会関東支部学術集会に参加して. in submission.
• 左中彩恵. 一歩踏み出した先にある世界-研究室演習で得た学びと気づき-.  in submission.
• 久保明澄. 第12回日本DoHAD学会学術集会に参加して. 2024_10.
• 佐々木哲也. 変革期を迎える日本のアカデミア：持続可能な研究環境の構築に向けて. 2024-11.
• 佐々木哲也. 書評_構造と機能がつながる神経解剖生理学. 医学書院. 2024_11. 
• 佐々木哲也. 医の精神を紡ぐ-筑波大学医学群における解剖実習と革新的医学教育の融合-. 2024-08. 
• 武井陽介. 変革期の医学教育と献体の意義. つくばしらぎく. 42: 1-2. 2024_09.
• 武井陽介. 令和6年篤志解剖体慰霊式「追慕の辞」.2024-10. 

2023

• Wan Y, Morikawa M, Morikawa M, Iwata S, Naseer MI, Chaudhary A, Tanaka Y, Hirokawa N. KIF4 regulates neuronal morphology and seizure susceptibility via the PARP1 signaling pathway.  J Cell Biol (2023) 222 (2): e202208108. 
• Sasaki T. Roles of immune molecules in the formation of the cerebral cortex and their abnormalities in psychiatric disorders. Frontiers in DOHaD Research. 2023. 11(2): 126-134.
• Kanamaru H, Nakano K. Analysis of actin reorganization and kinesin-2 member KIN2 in the ciliate Tetrahymena. Tsukuba Journal of Biology. 2023. 22(1): 12-12.
• Sasaki T. Prenatal Reprogramming and Autism Spectrum Disorder. Developmental Origins of Health and Disease Research. 11(1): 2023. 15-16.
• Sasaki T. Effects of constitutive increase of IL-17A in serum on central nervous system. Medical Science Digest. 2023.03. 1-2.
• Sasaki T, Kamiya S, Takahashi S, Takei Y. Cytokine balance modulation in psychiatric disorders. Developmental Origins of Health and Disease Research. 2023. 11(3): 36-36.
• 伊藤, 雅英, 岩田, 卓, 武井 陽介, 青木, 貞雄, 星野 鉄哉 2023-196244 軟 X 線回折の波長依存性を用いた厳密な３次元断面形状計測 
• 左中彩恵. 解剖学実習を終えて. つくばしらぎく. 2024.10.01.

2022

• Morikawa M, Jerath NU, Ogawa T, Morikawa M, Tanaka Y,  Shy ME , Zuchner S, Hirokawa N. A neuropathy-associated kinesin KIF1A mutation hyper-stabilizes the motor-neck interaction during the ATPase cycle. The EMBO Journal. 2022. e108899. 
• Morikawa M. Transport Mechanisms in Neurons Reveal Brain Functions and Psychiatric Diseases – Part I– M_hub. 2022. September 20, 2022.
• Morikawa M. What is important when working in multiple laboratories -Part 2-. M_hub. 2022. September 20, 2022.
• Sasaki T, Iwata S, Takei Y. Introduction of Laboratory: Laboratory of Anatomy and Neuroscience, Faculty of Medicine, University of Tsukuba. Structure and Function. 2022-03. 22(3): 76-78. 

2021

• Yoshihara S, Jiang X, Morikawa M, Ogawa T, Ichinose S, Yabe H, Kakita A, Toyoshima M, Kunii Y, Yoshikawa T, Tanaka Y, and Hirokawa N. Betaine ameliorates schizophrenic traits by functionally compensating for KIF3-based CRMP2 transport. Cell Reports. 2021. 35(2). AMEDプレスリリース. 
• Takahashi A, Aleyasin H, Stavarache M, Li L, Cathomas F, Parise LF, Lin H, C. Burnett J, Aubry A, Flanigan ME,  Brancato A, Menard C, Pfau LM, Kana V, Jun Wang J, Hodes GE, Sasaki T, Kaplitt MG, Ogawa S, McEwen BS & Russo SJ. Neuromodulatory effect of interleukin 1β in the dorsal raphe nucleus on individual differences in aggression. Molecular Psychiatry. 2021. 日本の研究.com QLifepro ニューロサイエンス学位プログラムWebsite 
• Sasaki T, Takahashi S, Takei Y. Enhanced maternal retinoic acid-related orphan receptor-γt enhances the effect of poly(i:c) in inducing fetal loss. DOHaD Research. 2021. 9(2): 78-78. 
• Shutoh F, Masuda T, Sasaki T, Takei Y. Anomalous atrium associated with persistent left superior vena cava. Anatomical Science International. 2021-01. 本論文の解説
• Sasaki T, Nagata R, Takahashi S, Takei Y. Effects of RORγt overexpression on the murine central nervous system. Neuropsychopharmacology Reports. 2021. 41(1): 102-110. 本論文の解説　筑波大学プレスリリース 日本の研究.com QLifepro m3.臨床ニュース ニューロサイエンス学位プログラムWebsite
• Sasaki T, Takei Y. Constitutive increase of IL-17A in serum affects microglial activity in the hippocampal dentate gyrus. Jap J Biol Psych. 2021. 32(2) 154-160.
• Sasaki T, Yabe K, Seya Y, Shutoh F, Takei Y. The Practice Report of Anatomy Lecture/Dissection of University of Tsukuba under COVID-19 Pandemic. Structure and Function. 2021-03. 19(2) 33-36. 
• Sasaki T, Nomura Y, Kinase K, Itoh H, Tsutsumi A. The Practice Report of online lecture in Nursing School under COVID-19 Pandemic. Structure and Function. 2021-03. 19(2) 37-40. 
• Zushi N, Iwasaki K, Wang T, Hasunuma K, Sasaki T. How to guide the hand out using the priming effect. Report of the Comprehensive Seminar of the Department of Kansei, Behavioral, and Brain Sciences. 2021. 1: 141-143.
• 武井陽介.  2021. コロナ禍のさなかで. つくば白菊. 2021-10. 39: 1-3.
• 岩田卓. 2021. 筑波大学着任の挨拶. 2021.03.01.
• 渡部嘉徳.  2021. 解剖学実習を終えて.  解剖学への招待. 2021.12.31.

2020

• Iwata S, Morikawa M, Takei Y, Hirokawa N. An activity-dependent local transport regulation via degradation and synthesis of KIF17 underlying cognitive flexibility. Science Advances 16 Dec 2020: Vol. 6(51). QLifePro 日本経済新聞  プレスリリース
• Sasaki T, Tome S, Takei Y. Intraventricular IL-17A Administration Activates Microglia and Alters Their Localization in the Mouse Embryo Cerebral Cortex. Mol Brain. 13:93. 2020. https://doi.org/10.1186/s13041-020-00635-z. 筑波大学 プレスリリース　日本の研究.com 　医学医療系トピックス　QLifePro Newton別冊精神の病気　ニューロサイエンス学位プログラムWebsite
• Sasaki T, Komatsu Y, Yamamori T. Expression patterns of SLIT/ROBO mRNAs reveal a characteristic feature in the entorhinal-hippocampal area of macaque monkeys. BMC Res Notes. 2020. 262(13) 1-6.
• Zhou C, Shutoh F, Komada H, Yamanaka T. Effects of Scent and Music on Moods and Stress in the Confined Resting Area. International Journal of Affective Engineering. 2020. 19 (3): 199-205. https://doi.org/10.5057/ijae.IJAE-D-19-00017. 
• Sasaki T, Bao P, Takada T, Takei T. Effects of IL-17A on activation and localization of microglia in murine cerebral cortex – Aiming to understand cortical abnormalities and ASD pathogenesis by IL-17A. Jap J Biol Psych. 2020. 31(3) 93-98. 
• Iwata S, Sasaki T, Takei Y. Imaging of activity-dependent local translation in dendrite using photoconvertible protein. Medical Science Digest. 2020 June; 45(6): 64-65.
• Sasaki T, Takei Y. Localization Mechanism of Myosin Id, an ASD Risk Gene Product in Dendritic Spines. Jap J Biol Psych. 2020, 31(2) 93-97.
• Sasaki T, Nagata R, Takahashi S, Takei Y. Effects of RORγt overexpression on the murine central nervous system. Research Square, 2020-05.
• Sasaki T, Tome S, Takei Y. Intraventricular IL-17A Administration Activates Microglia and Alters Their Localization in the Mouse Embryo Cerebral Cortex. Research Square, 2020-05.
• Sasaki T. Cortical areas and psychiatric disorders. The Naito Foundation Report. 2020. 106. 39-39. 
• Kobayakawa M, Matsubara T, Mizokami A, Hiura F, Takakura N, Kokabu S, Matsuda M, Yasuda H, Nakamura I, Takei Y, Honda H, Hosokawa R, Jimi E. Kif1c regulates osteoclastic bone resorption as a downstream molecule of p130Cas. Cell Biochem Func. 2020 Apr; 38(3):300-308. doi: 10.1002/cbf.3476.
• 廣川信隆、森川桃、原壮悟、田中庸介、武井陽介、小川覚之、吉川武男、國井泰人. KIF３モーターに基づく精神疾患の治療又は予防、及び薬物スクリーニング. (特許権)

2019

• Alsabban AH, Morikawa M, Tanaka Y, Takei Y, Hirokawa N. Kinesin Kif3b mutation reduces NMDAR subunit NR2A trafficking and causes schizophrenia‐like phenotypes in mice. EMBO J (2019) e101090. 筑波大学プレスリリース AMEDプレスリリース QLifePro
• Sasaki T. 「Participating in the 39th Human Anatomy Training Seminar」Report on the 39th Human Anatomy Training Seminar. Graduate School of Medicine, Nagoya University. 2019.12.
• 當銘幸貴, 佐々木哲也, 高橋智, 武井陽介. 2019. 母体レチノイン酸関連オーファン受容体γtの上昇は，ポリイノシン－ポリシチジル酸の流産誘導効果を高める. 実験動物ニュース. 68(4). 82-82. 
• Takei Y, Tome S, Sasaki T. KIF17-mediated transport of NMDA receptors and schizophrenia. Jap J Biol Psych. 2019. 30(3) 101-104 .
• Tome S. 「LEGEND Travel Award Program」Society Report (Participating Society: 124th Annual Meeting of the Japanese Society of Anatomy, National Academic Meeting). 2019.04.01.
• Tome S, Sasaki T, Takahashi S, Takei Y. Elevated maternal retinoic acid-related orphan receptor-γt enhances the effect of polyinosinic-polycytidylic acid in inducing fetal loss. Exp Animals. 2019. Jun 10.
• Nogami H, Koshida R, Omori H, Shibata M, Harigaya Y, Takei Y. Inhibition of epidermal growth factor receptor stimulates PRL expression in primary culture of the mouse pituitary gland. J Endoc. 2019. 31(8) 1-8. 
• Maimaiti S, Koshida R, Ojima M, Kulathunga K, Oishi H, Takahashi S. Neuron-specific Mafb knockout causes growth retardation accompanied by an impaired growth hormone/insulin-like growth factor I axis. Exp Anim. 2019 Nov 6;68(4): 435-442.
• Sasaki T, Komatsu Y, Yamamori T. Prefrontal-Enriched SLIT1 Expression in Primate Cortex and its Alteration during Cortical Development. Jap J Biol Psych. 2019. 30(2). 81-85

2018

• Koshida R, Tome S, Takei Y. Myosin Id localizes in dendritic spines through the tail homology 1 domain. Exp Cell Res. 2018;367(1):65-72.
• Okumura E, Shuto F, Yamanaka T. How different patterns affect in feelings of goodness? Int J Affec Eng. 2018; 17(2) 119-126.
• Morito N, Yoh K, Usui T, Oishi H, Ojima M, Fujita A, Koshida R, Shawki H, Hamada M, Muratani M, Yamagata K, Takahashi S. Transcription factor MafB may play an important role in secondary hyperparathyroidism. Kidney Int. 2018 Jan;93(1):54-68. 
• Sasaki T. 「LEGEND Travel Award Program」Society Report (Participating Society: 41th Annual Meeting of Japan Neuroscience Society). 2018.09.01.
• Sasaki T.「Participating in the 38th Human Anatomy Training Seminar」Report on the 38th Human Anatomy Training Seminar. Graduate School of Medicine, Nagoya University. 2018.12.

2017

• Mitsumori, Takei Y, Hirokawa N. Components of RNA granules affect their localization and dynamics in neuronal dendrites. Mol Biol Cell. 2017;28(11):1412-1417.
• Koshida R, Oishi H, Hamada M, Takei Y, Takahashi S. MafB is required for development of the hindbrain choroid plexus. Biochem Biophys Res Commun. 2017;483(1):288-29
• Masuda T, Itoh J, Koide T, Tomidokoro Y, Takei Y, Ishii K, Tamaoka A. Transforming growth factor-β1 in the cerebrospinal fluid of patients with distinct neurodegenerative diseases. J Clin Neurosci. 2017;35:35-47.
• Tran MTN, Hamada M, Jeon H, Shiraishi R, Asano K, Hattori M, Nakamura M, Imamura Y, Tsunakawa Y, Fujii R, Usui T, Kulathunga K, Andrea CS, Koshida R, Kamei R, Matsunaga Y, Kobayashi M, Oishi H, Kudo T,  and Takahashi S. MafB is a critical regulator of complement component C1q. Nat Comm. 2017. 1700 (8).
• Shichita T, Ito M, Morita R, Komai K, Noguchi Y, Ooboshi H, Koshida R, Takahashi S, Kodama T, Yoshimura A. MAFB prevents excess inflammation after ischemic stroke by accelerating clearance of damage signals through MSR1. 2017; Nat Med 23. 723–732.
• 武井陽介. スパイン内ＮＭＤＡ受容体輸送機構の解明. 上原記念生命科学財団研究報告集. 2017; 31: 47-47.

2016

• 武井陽介. 筑波大学教授就任にあたってー自己紹介と研究ー. 解剖学雑誌. 2016. 91; 19-20
• 武井陽介. 教授就任の挨拶. 桐医会会報 2016. 3; 3-4
• 武井陽介, 廣川信隆. 微小管結合蛋白によるNMDA 受容体輸送調節と神経可塑性. 顕微鏡. 2016. 51(1): 9-12.

2015

• Takei Y, Kikkawa YS, Atapour N, Hensch TK, Hirokawa N. Defects in synaptic plasticity, reduced NMDA-Receptor transport, and instability of postsynaptic density proteins in mice lacking microtubule-associated protein 1A. J Neurosci. 2015;35(47):15539-54. PubMed プレスリリース（筑波大学、東京大学）
• Farkhondeh A, Niwa S, Takei Y, Hirokawa N. Characterizing KIF16B in neurons reveals a novel intramolecular “stalk inhibition” mechanism that regulates its capacity to potentiate the selective somatodendritic localization of early endosomes. J Neurosci. 2015;35(12):5067-86.
• Sugimoto K, Ohmomo H, Shutoh F, Nogami H, Hisano S. Presentation of noise during acute restraint stress attenuates expression of immediate early genes and arginine vasopressin in the hypothalamic paraventricular nucleus but not corticosterone secretion in rats. Neurosci Res. 2015; 96:20-29.
• 武井陽介. 解剖学実習は学生を変える. 筑波しらぎく. 巻頭言

Before 2015

2014

• Seya Y and Yabe K. 2014. Anatomical Work for Medical Education Practice. 第13回筑波大学技術職員技術発表会報告集 34: 65-69.
• Yabe K an Seya Y. 2014. 局所排気装置付解剖台による実習室内ホルムアルデヒド濃度低減効果. 第13回筑波大学技術職員技術発表会報告集 34: 01-06.
• 菅江 則子, 小野瀬 惠里子, 嶋村 玲子, 廣瀬 美鈴, 水代 祐子, 岩本 いく子 , 枝川 弥生 , 阿部まゆみ , 大里 和美, 土田 聡美 , 佐藤 尚江, 瀬谷 祐一, 矢部 一徳, 郷田 規久子, 森本 喜代子,乾 左徒子, 木内 美紀, 丹波 道子, 酒井 由紀. 医学系技術室における教育支援（教育部門）筑波大学技術報告. 34: 74-78.

2012

• Nakajima K, Yin X, Takei Y, Seog DH, Homma N, Hirokawa N. 2012. Molecular Motor KIF5A Is Essential for GABAA Receptor Transport, and KIF5A Deletion Causes Epilepsy. Neuron. 76(5): 945-961. https://doi.org/10.1016/j.neuron.2012.10.012. 
• Yin X, Feng X, Takei Y, Hirokawa N. 2012. Regulation of NMDA Receptor Transport: A KIF17-cargo Binding/Releasing Underlies Synaptic Plasticity and Memory in Vivo. J Neurosci. 2012 Apr 18;32(16):5486-99. doi: https://doi.org/10.1523/JNEUROSCI.0718-12.
• Kondo M, Takei Y, Hirokawa N. 2012. Motor protein KIF1A is essential for hippocampal synaptogenesis and learning enhancement in an enriched environment. Neuron. Feb 23;73(4):743-57. doi: 10.1016/j.neuron.2011.12.020.

2011

• Yin X, Takei Y, Kido MA, Hirokawa N.. 2011. Molecular motor KIF17 is fundamental for memory and learning via differential support of synaptic NR2A/2B levels. Neuron. 2011 Apr 28;70(2):310-25. doi: 10.1016/j.neuron.2011.02.049.

2010

• Terada S, Kinjo M, Aihara M, Takei Y, Hirokawa N. Kinesin-1/Hsc70-dependent mechanism of slow axonal transport and its relation to fast axonal transport. EMBO J. 2010 Feb 17;29(4):843-54. doi: 10.1038/emboj.2009.389. Epub 2010 Jan 28.

2009

• Zhou R, Niwa S, Homma N, Takei Y, Hirokawa N. 2009. KIF26A Is an Unconventional Kinesin and Regulates GDNF-Ret Signaling in Enteric Neuronal Development. Cell 2009 Nov 13;139(4):802-13. https://doi: 10.1016/j.cell.2009.10.023.

2007

• Yabe K and Seya Y. 2007. 献体業務及び解剖実習時の環境改善について〜感染症防止及びホルムアルデヒド対策〜 2007. 筑波大学技術報告. 27: 1-5

2006

• Midorikawa R, Takei Y, Hirokawa N. 2006. KIF4 motor regulates activity-dependent neuronal survival by suppressing PARP-1 enzymatic activity. Cell. 2006 Apr 21;125(2):371-83. doi: 10.1016/j.cell.2006.02.039.

2005

• Teng J, Rai T, Tanaka Y, Takei Y, Nakata T, Hirasawa M, Kulkarni AB, Hirokawa N. The KIF3 motor transports N-cadherin and organizes the developing neuroepithelium. Nat Cell Biol. 2005 May;7(5):474-82. doi: 10.1038/ncb1249. Epub 2005 Apr 17.

2003

• Homma N, Takei Y, Tanaka Y, Nakata T, Terada S, Kikkawa M, Noda Y, Hirokawa N. Kinesin superfamily protein 2A (KIF2A) functions in suppression of collateral branch extension. Cell. 2003 Jul 25;114(2):229-39. doi: 10.1016/s0092-8674(03)00522-1.

2002

• Wong RW, Setou M, Teng J, Takei Y, Hirokawa N. Overexpression of motor protein KIF17 enhances spatial and working memory in transgenic mice. Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14500-5. doi: 10.1073/pnas.222371099. Epub 2002 Oct 21.
• Harada A, Teng J, Takei Y, Oguchi K, Hirokawa N. MAP2 is required for dendrite elongation, PKA anchoring in dendrites, and proper PKA signal transduction. J Cell Biol. 2002 Aug 5;158(3):541-9. doi: 10.1083/jcb.200110134. Epub 2002 Aug 5.
• Setou M, Seog DH, Tanaka Y, Kanai Y, Takei Y, Kawagishi M, Hirokawa N. Glutamate-receptor-interacting protein GRIP1 directly steers kinesin to dendrites. Nature. 2002 May 2;417(6884):83-7. doi: 10.1038/nature743.
• Nakajima K, Takei Y, Tanaka Y, Nakagawa T, Nakata T, Noda Y, Setou M, Hirokawa N. Molecular motor KIF1C is not essential for mouse survival and motor-dependent retrograde Golgi apparatus-to-endoplasmic reticulum transport. Mol Cell Biol. 2002 Feb;22(3):866-73. doi: 10.1128/mcb.22.3.866-873.2002.

2001

• Teng J, Takei Y, Harada A, Nakata T, Chen J, Hirokawa N. Synergistic effects of MAP2 and MAP1B knockout in neuronal migration, dendritic outgrowth, and microtubule organization. J Cell Biol. 2001 Oct 1;155(1):65-76. doi: 10.1083/jcb.200106025.
• Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, Takeda S, Yang HW, Terada S, Nakata T, Takei Y, Saito M, Tsuji S, Hayashi Y, Hirokawa N. Charcot-Marie-Tooth Disease Type 2A Caused by Mutation in a Microtubule Motor KIF1Bbeta. Cell. 2001 Jun 1;105(5):587-97. doi: 10.1016/s0092-8674(01)00363-4. 

2000

• Takei Y, Teng J, Harada A, Hirokawa N. Defects in Axonal Elongation and Neuronal Migration in Mice With Disrupted Tau and map1b Genes. J Cell Biol. 2000 Sep 4;150(5):989-1000. doi: 10.1083/jcb.150.5.989.

1999

• Terada S, Tsujimoto T, Takei Y, Takahashi T, Hirokawa N. Impairment of Inhibitory Synaptic Transmission in Mice Lacking Synapsin I. J Cell Biol. 1999 May 31;145(5):1039-48. doi: 10.1083/jcb.145.5.1039.

1998

• Yonekawa Y, Harada A, Okada Y, Funakoshi T, Kanai Y, Y Takei Y, Terada S, Noda T, Hirokawa N. Defect in Synaptic Vesicle Precursor Transport and Neuronal Cell Death in KIF1A Motor Protein-Deficient Mice. J Cell Biol 1998 Apr 20;141(2):431-41. doi: 10.1083/jcb.141.2.431.
• Harada A, Takei Y, Kanai Y, Tanaka Y, Nonaka S, Hirokawa N. Golgi Vesiculation and Lysosome Dispersion in Cells Lacking Cytoplasmic Dynein. J Cell Biol. 1998 Apr 6;141(1):51-9. doi: 10.1083/jcb.141.1.51.

1997

• Takei Y, Kondo S, Harada A, Inomata S, Noda T, Hirokawa N. Delayed Development of Nervous System in Mice Homozygous for Disrupted Microtubule-Associated Protein 1B (MAP1B) Gene. 1997 Jun 30;137(7):1615-26. doi: 10.1083/jcb.137.7.1615.

1995

• Takei Y, Harada A, Takeda S, Kobayashi K, Terada S, Noda T, Takahashi T, Hirokawa N. Synapsin I Deficiency Results in the Structural Change in the Presynaptic Terminals in the Murine Nervous System. J Cell Biol. 1995 Dec;131(6 Pt 2):1789-800. doi: 10.1083/jcb.131.6.1789.

1994

• Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, Sato-Yoshitake R, Takei Y, Noda T, Hirokawa N. Altered Microtubule Organization in Small-Calibre Axons of Mice Lacking Tau Protein. Nature. 1994 Jun 9;369(6480):488-91. doi: 10.1038/369488a0.